CRCrystal M. Ripplinger

Crystal M. Ripplinger

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Crystal M. Ripplinger has a total of 404 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Targeting Arrhythmogenic Late Sodium Current by FHF1 A -Derivative FixR in Heart Failure Cardiomyocytes

    by Bence Hegyi, Paweorn Angsutararux, Nourdine Chakouri, Ryan W. Mahling, Lucile Fossier, Hai M. Nguyen, Shannon Gilhooly, Victor Alencar Almeida, Charlotte E.R. Smith, Lianguo Wang, et al.

    BACKGROUND: Enhanced late Na + current (I Na,L ) in heart failure (HF) contributes to cardiomyocyte proarrhythmia. In addition to CaMKII (Ca 2+ /calmodulin-dependent protein kinase II), FGF (fibroblast growth factor) homologous factors 1–4 (FHF1–4) also modulate I Na,L , and targeting these pathways may provide benefits in HF. METHODS: Reverse-transcriptase quantitative polymerase chain reaction analysis of cardiac Na + channel and FHF splice isoforms was performed in human arrhythmogenic HF with reduced ejection fraction (HFrEF) and in translational animal models of HFrEF and HF with preserved ejection fraction. We tested the effects of an FixR (FHF inhibiting x region) on cardiomyocyte I Na,L and electrophysiology in rabbit HFrEF and murine models of HFrEF and HF with preserved ejection fraction. We also tested the in vivo electrophysiological effects of FixR via adenoviral delivery in transgenic mice with cardiomyocyte-specific overexpression of CaMKIIδ C . RESULTS: Expression of key FHF long isoforms (FHF1 A in humans, FHF2 S in rabbits, and FHF2 VY in mice) that have inhibitory effects on I Na,L was reduced in human, rabbit, and murine failing hearts. I Na,L was markedly enhanced in both HFrEF and HF with preserved ejection fraction, and the FixR cell-penetrating peptide significantly reduced pathological I Na,L in both forms of HF. FixR had no effect on transient peak Na + current, L-type Ca 2+ current, or major K + currents in rabbit ventricular myocytes. FixR markedly attenuated proarrhythmogenic action potential changes (increased action potential duration, short-term variability, and alternans susceptibility) and delayed afterdepolarizations in both rabbit and murine failing cardiomyocytes. These cellular antiarrhythmic effects were mimicked by the selective I Na,L inhibitor GS967 and the CaMKII inhibitor AIP (autocamtide-2 inhibitory peptide). FixR also attenuated QT prolongation and in vivo arrhythmia susceptibility in transgenic mice with cardiomyocyte-specific overexpression of CaMKIIδ C . CONCLUSIONS: In HF, I Na,L is increased, and FHF splice isoform expression is altered, allowing a novel mechanism to therapeutically target I Na,L . FixR, an FHF1 A -derived peptide, is a potent and selective I Na,L inhibitor and has antiarrhythmic properties in both HFrEF and HF with preserved ejection fraction cardiomyocytes.


  • Open Access

    Sex-specific electrophysiology and cholinergic responses underlie differential mechanisms of arrhythmia vulnerability in rabbit atria

    by Charlotte E. R. Smith, Lianguo Wang, Amanda M. Guevara, Lilian R. Mott, Haibo Ni, Eleonora Grandi, Crystal M. Ripplinger

    Background: Sex differences in the epidemiology of atrial fibrillation are well-documented; however, the underlying mechanisms remain poorly understood. This gap in knowledge is compounded by limited data on sex-specific atrial electrophysiology in the absence of disease. Objectives: The aim of this study was to investigate sex differences in atrial electrophysiology and arrhythmia susceptibility in a translationally-relevant rabbit model. Methods: Dual optical mapping of transmembrane voltage and Ca 2+ was performed on intact atria of young (3.5-5 months) male and female rabbit hearts. Baseline atrial electrophysiology and arrhythmia susceptibility were investigated using rapid pacing and premature stimulation and further tested with the parasympathomimetic carbachol. Sex and regional differences in gene expression were assessed using qPCR. Results: Females exhibited similar action potential duration (APD), but greater APD heterogeneity across the atria at slower rates, along with longer Ca 2+ transient durations compared to males. Greater APD heterogeneity in females was rate-dependent and comparable to males at faster pacing frequencies; however, it was associated with greater susceptibility to transient reentrant arrhythmias with premature stimuli. After carbachol application, males had heightened vulnerability to arrhythmia. This was associated with cholinergic-mediated APD shortening in both atria in males, but only in the right atrium in females. Sex differences in carbachol responses were linked to variations in muscarinic receptor and acetylcholine-activated potassium channel gene expression. Conclusions: These findings demonstrate sex and regional differences in atrial electrophysiology at baseline and in response to cholinergic stimulation in the healthy heart that may contribute to sex-specific mechanisms of arrhythmia.


  • Open Access

    Multiparametric imaging of spatio-temporal cAMP signaling, transmembrane potential, and intracellular calcium in the intact heart

    by I-Ju E. Lee, Jessica L. Caldwell, Lilian R. Mott, Jorge L. Gonzalez, Lianguo Wang, Crystal M. Ripplinger

  • Beat‐to‐beat QT interval variability as a tool to detect the underlying cellular mechanisms of arrhythmias

    by Daisuke Sato, Bence Hegyi, Crystal M. Ripplinger, Donald M. Bers

    Increased beat‐to‐beat QT interval variability (QTV) on the electrocardiogram (ECG) has been associated with arrhythmia risk and sudden cardiac death. However, the underlying mechanisms driving increased QTV are not fully understood. Our previous work showed that membrane voltage instability is a major contributor to QTV. In this study, we investigated how intracellular calcium (Ca2+) cycling instability is also a major contributor to QTV using a mathematical model of a ventricular myocyte that incorporates stochastic ion channel gating and detailed Ca2+ cycling. By independently modulating membrane voltage instability (via the L‐type Ca2+ channel recovery time constant, τf) and intracellular Ca2+ cycling instability (via the steepness of the sarcoplasmic reticulum Ca2+ release‐load relationship, u), we show that both voltage and Ca2+ instabilities significantly increase action potential duration (APD) variability, which contributes to QTV, even in the absence of overt arrhythmic patterns. Ca2+ transient variability increases with intracellular Ca2+ cycling instability, contributing to APD variability via Ca2+‐sensitive currents, and consequently to QTV. Notably, APD variability/QTV significantly increases just before the onset of alternans, regardless of whether instability originates from voltage or Ca2+ dynamics. Thus, QTV may serve as a precursor to both voltage‐driven and Ca2+‐driven alternans. Furthermore, pharmacological interventions that selectively stabilize voltage vs. Ca2+ cycling may selectively reduce QTV. These findings suggest that QTV can help distinguish between arrhythmias caused by electrical dysfunction and those caused by Ca2+ cycling dysfunction. Therefore, QTV has potential as a non‐invasive tool not only to identify individuals at risk but also to predict the specific type and underlying cause of arrhythmias. image Key points: Both membrane voltage and intracellular Ca2+ cycling instabilities contribute to increased QTV, even without overt arrhythmic patterns. Ca2+ transient variability increases with intracellular Ca2+ cycling instability and independently contributes to QTV, regardless of voltage instability. QTV serves as a precursor to both electrical and Ca2+ alternans, highlighting its potential as an early non‐invasive marker for arrhythmic events. The response of QTV to specific pharmacological interventions may differentiate between voltage‐driven and Ca2+‐driven instability, guiding personalized treatment strategies. The study suggests QTV as a promising tool for personalized arrhythmia risk assessment and mechanism‐specific therapeutic strategies.


  • Progress on incorporating sex as a biological variable in cardiovascular research

    by Merry L. Lindsey, Amanda J. LeBlanc, Crystal M. Ripplinger, Zamaneh Kassiri, Jonathan A. Kirk, Petra Kleinbongard, Jason R. Carter, Keith R. Brunt


  • Open Access

    Multi-parametric imaging of spatio-temporal cAMP signaling, transmembrane potential, and intracellular calcium in the Langendorff-perfused heart

    by I-Ju E. Lee, Jessica L. Caldwell, Lilian R. Mott, Lianguo Wang, Crystal M. Ripplinger

    Summary: The spatiotemporal dynamics of intracellular second messengers and signaling molecules, including cyclic adenosine monophosphate (cAMP), have been studied extensively in isolated cardiomyocytes using Förster resonance energy transfer (FRET)-based reporters. However, little is known about how molecular signaling events affect tissue-level function. Optical mapping of transmembrane potential (V m ) and intracellular calcium (Ca 2+ i ) is frequently performed in isolated intact hearts to reveal tissue-level electrophysiological function but cannot reveal molecular underpinnings. Here, we developed a novel multi-parametric optical imaging system that enables multi-parametric recording of four wavelengths to visualize cAMP and real-time electrophysiological responses (V m and Ca 2+ i ) by utilizing concurrent FRE T imaging and d ual o ptical m apping (FRE-DOM) in the intact heart from a cardiac-specific FRET-based cAMP reporter mouse. We showed that cAMP is strongly and heterogeneously activated throughout the heart (atria and ventricles) in response to β-AR stimulation, the time course of which matches heart rate, action potential, and Ca 2+ responses. This novel imaging system will provide insight into the relationship between cAMP signaling, electrophysiology, and arrhythmogenesis at high spatio-temporal resolution.

  • Open Access

    Neurocardiology: translational advancements and potential

    by N. Herring, O. A. Ajijola, R. D. Foreman, A. V. Gourine, A. L. Green, J. Osborn, D. J. Paterson, J. F. R. Paton, C. M. Ripplinger, C. Smith, et al.

    In our original white paper published in the The Journal of Physiology in 2016, we set out our knowledge of the structural and functional organization of cardiac autonomic control, how it remodels during disease, and approaches to exploit such knowledge for autonomic regulation therapy. The aim of this update is to build on this original blueprint, highlighting the significant progress which has been made in the field since and major challenges and opportunities that exist with regard to translation. Imbalances in autonomic responses, while beneficial in the short term, ultimately contribute to the evolution of cardiac pathology. As our understanding emerges of where and how to target in terms of actuators (including the heart and intracardiac nervous system (ICNS), stellate ganglia, dorsal root ganglia (DRG), vagus nerve, brainstem, and even higher centres), there is also a need to develop sensor technology to respond to appropriate biomarkers (electrophysiological, mechanical, and molecular) such that closed‐loop autonomic regulation therapies can evolve. The goal is to work with endogenous control systems, rather than in opposition to them, to improve outcomes. image


  • Open Access

    Sympathetic structural and electrophysiological remodeling in a rabbit model of reperfused myocardial infarction

    by Amanda Guevara, Charlotte E. R. Smith, Lianguo Wang, Jessica L. Caldwell, Srinivas Tapa, Samantha D. Francis Stuart, Betty W. Ma, G. Andre Ng, Beth A. Habecker, Zhen Wang, et al.

    Here, we show that CSPGs are present in the infarcts of rabbit hearts with reperfused MI, where they are associated with reduced sympathetic nerve density. Despite hypoinnervation, sympathetic responsiveness is maintained or enhanced in MI rabbit hearts, which also demonstrate increased APD dispersion and tendency for arrhythmias following sympathetic modulation. Together, this study indicates that the mechanisms of sympathetic remodeling post-MI are similar between rodents and rabbits, with hypoinnervation likely associated with enhanced β-adrenergic sensitivity.


  • Open Access

    Sympathetic structural and electrophysiological remodeling in a rabbit model of reperfused myocardial infarction

    by Amanda Guevara, Charlotte E.R. Smith, Lianguo Wang, Jessica L. Caldwell, Srinivas Tapa, Samantha D. Francis Stuart, Betty W. Ma, G. Andre Ng, Beth A. Habecker, Zhen Wang, et al.

    Chondroitin sulfate proteoglycans (CSPGs) inhibit sympathetic reinnervation in rodent hearts post myocardial infarction (MI), causing regional hypo-innervation that is associated with supersensitivity of β-adrenergic receptors and increased arrhythmia susceptibility. To investigate the role of CSPGs and hypo-innervation in the heart of larger mammals, we used a rabbit model of reperfused MI and tested electrophysiological responses to sympathetic nerve stimulation (SNS). Innervated hearts from MI and sham rabbits were optically mapped using voltage and Ca 2+ -sensitive dyes. SNS was performed with electrical stimulation of the spinal cord and β-adrenergic responsiveness was tested using isoproterenol. Sympathetic nerve density and CSPG expression were evaluated using immunohistochemistry. CSPGs were robustly expressed in the infarct and border zone of all MI hearts, and the presence of CSPGs was associated with reduced sympathetic nerve density in the infarct vs. remote region. Action potential duration (APD) dispersion and susceptibility to ventricular tachycardia/fibrillation (VT/VF) were increased with SNS in MI hearts but not in sham. SNS decreased APD 80 in MI but not sham hearts, while isoproterenol decreased APD 80 in both groups. Isoproterenol also shortened Ca 2+ transient duration (CaTD 80 ) in both groups but to a greater extent in MI hearts. Our data suggest sympathetic remodeling post-MI is similar between species, with CSPGs associated with sympathetic hypo-innervation. Despite a reduction in sympathetic nerve density, the infarct region of MI hearts remained responsive to both physiological SNS and isoproterenol, potentially through preserved or elevated β-adrenergic responsiveness, which may underly increased APD dispersion and susceptibility for VT/VF. NEW & NOTEWORTHY: Here we show that CSPGs are present in the infarcts of rabbit hearts with reperfused MI, where they are associated with reduced sympathetic nerve density. Despite hypo-innervation, sympathetic responsiveness is maintained or enhanced in MI rabbit hearts, which also demonstrate increased APD dispersion and tendency for arrhythmias following sympathetic modulation. Together, this study indicates that the mechanisms of sympathetic remodeling post-MI are similar between species, with hypo-innervation likely associated with enhanced β-adrenergic sensitivity.

  • Chronic nicotine exposure is associated with electrophysiological and sympathetic remodeling in the intact rabbit heart

    by Amanda Guevara, Charlotte E. R. Smith, Jessica L. Caldwell, Lena Ngo, Lilian R. Mott, I-Ju Lee, Srinivas Tapa, Zhen Wang, Lianguo Wang, William R. Woodward, et al.

    Nicotine is the primary addictive component in tobacco products. Through its actions on the heart and autonomic nervous system, nicotine exposure is associated with electrophysiological changes and increased arrhythmia susceptibility. To assess underlying mechanisms, we treated rabbits with transdermal nicotine (NIC, 21 mg/day) or control (CT) patches for 28 days prior to performing dual optical mapping of transmembrane potential (RH237) and intracellular Ca2+ (Rhod-2 AM) in isolated hearts with intact sympathetic innervation. Sympathetic nerve stimulation (SNS) was performed at the 1st - 3rd thoracic vertebrae, and β-adrenergic responsiveness was additionally evaluated following norepinephrine (NE) perfusion. Baseline ex vivo HR and SNS stimulation threshold were higher in NIC vs. CT (P = 0.004 and P = 0.003, respectively). Action potential duration alternans emerged at longer pacing cycle lengths (PCL) in NIC vs. CT at baseline (P = 0.002) and during SNS (P = 0.0003), with similar results obtained for Ca2+ transient alternans. SNS shortened the PCL at which alternans emerged in CT but not NIC hearts. NIC exposed hearts tended to have slower and reduced HR responses to NE perfusion, but ventricular responses to NE were comparable between groups. While fibrosis was unaltered, NIC hearts had lower sympathetic nerve density (P = 0.03) but no difference in NE content vs. CT. These results suggest both sympathetic hypo-innervation of the myocardium and regional differences in β-adrenergic responsiveness with NIC. This autonomic remodeling may contribute to the increased risk of arrhythmias associated with nicotine exposure, which may be further exacerbated with long-term use.